PROGENICS PHARMACEUTICALS

Summary

Progenics Pharmaceuticals is an oncology company developing innovative medicines and artificial intelligence to find, fight and follow cancer.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 423 M

Avg. Deal Size£ 423 M

Market Context

Senior Management